IVX 0.00% 0.2¢ invion limited

Morgan's Research, page-7

  1. 147 Posts.
    lightbulb Created with Sketch. 6
    Extract from Chairman's letter to shareholder's for rights issue.

    "Invion is currently completing its INV103 (ala-Cpn10) and INV102 (nadolol) programs, with pivotal data anticipated within three to four months. Based on recent transactions in the industry it is anticipated that this data will enable the Company to negotiate a strategic investment by a recognised biotech fund, or provide a platform for the sale of the Company or its assets within six months. "
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $13.33M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $6.251K 2.967M

Buyers (Bids)

No. Vol. Price($)
47 43316984 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 4352691 8
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.